home / stock / vtrs / vtrs news


VTRS News and Press, Viatris Inc. From 11/06/23

Stock Information

Company Name: Viatris Inc.
Stock Symbol: VTRS
Market: NASDAQ
Website: viatris.com

Menu

VTRS VTRS Quote VTRS Short VTRS News VTRS Articles VTRS Message Board
Get VTRS Alerts

News, Short Squeeze, Breakout and More Instantly...

VTRS - IHE: You Better Like Eli Lilly And Johnson & Johnson To Buy This

2023-11-06 15:44:53 ET Summary The iShares U.S. Pharmaceuticals ETF provides targeted exposure to the U.S. pharmaceutical industry but has a highly concentrated portfolio. The IHE ETF's top five holdings, including Eli Lilly and Johnson & Johnson, account for over 63% of the f...

VTRS - J&J's patent win against Viatris referred back to lower court

2023-11-06 15:01:08 ET More on J&J, Pfizer, etc. Pfizer: Value Investment Opportunity After Recent Price Decline Pfizer Inc. (PFE) Q3 2023 Earnings Call Transcript Pfizer Inc. 2023 Q3 - Results - Earnings Call Presentation Viatris Q3 2023 Earnings Preview...

VTRS - Viatris Q3 2023 Earnings Preview

2023-11-06 12:59:29 ET More on Viatris Viatris: Get Paid 5%, Before Growth Materializes Viatris' Survival Guide: Strategic Divestitures And Margins Viatris: Generic Semaglutide Could Become The Poor Man's Option For Weight Loss Theravance, Mylan settle patent...

VTRS - Pfizer: Value Investment Opportunity After Recent Price Decline

2023-11-02 09:00:00 ET Summary Pfizer's stock has dropped due to a decline in revenues post-COVID, presenting a value investment opportunity. The company still generates significant gross profit and has a strong revenue growth rate. Pfizer's low Price-to-Earnings ratio and imp...

VTRS - Ozempic Just Shrugged Off a Challenge From Viatris. What Does This Mean for Investors?

2023-10-31 05:05:00 ET As you may have heard, Novo Nordisk (NYSE: NVO) makes Ozempic, the type 2 diabetes medication sweeping the globe and raking in billions in the process. Where there's a money-printing drug in ascent, there's almost always a dispute about exactly who is the righ...

VTRS - Theravance, Mylan settle patent litigation over COPD drug Yupelri

2023-10-30 18:50:40 ET More on Theravance Biopharma, Teva Pharmaceutical, etc. Viatris: Get Paid 5%, Before Growth Materializes Viatris' Survival Guide: Strategic Divestitures And Margins Viatris: Generic Semaglutide Could Become The Poor Man's Option For Weight Loss...

VTRS - Viatris to Host Webinar: The Power of Partnership to Address Antimicrobial Resistance

Viatris to Host Webinar: The Power of Partnership to Address Antimicrobial Resistance PR Newswire PITTSBURGH , Oct. 30, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, announced today it is hosting The Power of Partnership to ...

VTRS - Pharma, PBMs spar over rising drug costs amid public scrutiny

2023-10-29 12:00:27 ET More on PBMs Cigna PBM unit Express Scripts sued for overcharging pharmacies FTC investigating purchasing organizations that work on behalf of PBMs Eli Lilly, Novo, Sanofi and leading PBMs accused in California over insulin prices CVS H...

VTRS - Viatris downgraded at BofA citing business transition

2023-10-23 13:41:19 ET More on Viatris Viatris: Get Paid 5%, Before Growth Materializes Viatris' Survival Guide: Strategic Divestitures And Margins Viatris: Generic Semaglutide Could Become The Poor Man's Option For Weight Loss 4 stocks to watch on Monday: Vi...

VTRS - Viatris Named to Forbes' Annual List of the World's Best Employers for the Third Year in a Row

Viatris Named to Forbes' Annual List of the World's Best Employers for the Third Year in a Row PR Newswire PITTSBURGH , Oct. 23, 2023 /PRNewswire/ -- Viatris Inc . (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to Forb...

Previous 10 Next 10